CRC 220

Also Known As:

4-methoxy-2,3,6-trimethylphenylsulfonyl-L-aspartyl-D-amidinophenylalanine-piperidide; CRC-220

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

1.	Thrombosis (Thrombus) 02/15/1995 - "We evaluated the efficacy of CRC 220 to prevent thrombus formation in arteries and in the microcirculation in different animal models. " 02/15/1995 - "The i.v. bolus administration of CRC 220 dose-dependently prevented thrombus formation, an ED50 of 0.03 mg/kg was calculated. "
2.	Adenoma (Adenomas) 06/01/2015 - "A total of 13 studies including 716 patients with CRC 220 cases of adenoma and 414 healthy controls were eligible for final analysis. "